Bruker's CBRNE Detection Bus. Announces Contract Award for Ten First Article Test Systems for US Navy Improved Point Detectio...

Bruker Detection Corporation today announced that it has been awarded a contract for ten (10) first article test and verification units for the Improved Point Detection System (IPDS) replacement program of the United States Navy, based on Bruker’s RAID™-S2 shipboard chemical detector. The award includes ten units and certain engineering modifications, with a total contract amount greater than one million dollars.

Bruker’s RAID-S2 is a gas trace detector for the detection of chemical warfare agents (CWAs) and toxic industrial chemicals (TICs). It is based on advanced high-performance ion mobility spectrometry (IMS) technology. The RAID-S2 is specifically designed for long-term monitoring of ambient air for the presence of hazardous chemical vapors in the interior or exterior of ships, buildings or shelters.

Mr. Frank Thibodeau, Vice President of Bruker Detection Corporation, commented: “The IPDS evaluation program consisted of a challenging competitive testing regime under demanding environments which pushed the limits of chemical point detection systems. The RAID-S2 performed very well in these evaluation trials and has been selected by the U.S. Department of Defense for final test and validation of production units. We are delighted to have been selected for the IPDS program by the US Navy, and believe that Bruker’s robust and proven RAID™ IMS technology, unsurpassed detection capability, and proprietary industry-leading false-alarm suppression have led to this contract award. These technological features are also built into our industry-leading RAID™-M handheld detector, RAID™-XP portable combined chemical and gamma radiation detector, as well as our RAID™-AFM Autonomous Facility Monitor for critical building and infrastructure protection, which has been developed under a separate Department of Homeland Security development contract.”

ABOUT BRUKER DETECTION

For more information about Bruker’s CBRNE Detection Business and Bruker Corporation (NASDAQ: BRKR), please visit www.bruker.com/detection

CAUTIONARY STATEMENT

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to adverse changes in conditions in the global economy and volatility in the capital markets, the integration of businesses we have acquired or may acquire in the future, changing technologies, product development and market acceptance of our products, the cost and pricing of our products, manufacturing, competition, dependence on collaborative partners and key suppliers, capital spending and government funding policies, changes in governmental regulations, intellectual property rights, litigation, and exposure to foreign currency fluctuations. These and other factors are identified and described in more detail in our filings with the SEC, including, without limitation, our annual report on Form 10-K for the year ended December 31, 2008, our most recent quarterly reports on Form 10-Q and our current reports on Form 8-K. We disclaim any intent or obligation to update these forward-looking statements other than as required by law.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5994744&lang=en